fluorescein-5-isothiocyanate has been researched along with transforming growth factor beta in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (20.00) | 18.2507 |
| 2000's | 16 (64.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 3 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aurbach, GD; Brandi, ML; Curcio, F; Fattorossi, A; Lelkes, PI; Matsui, T; Ornberg, RL; Sakaguchi, K; Zimering, M | 1 |
| Adler, WH; Chrest, FJ; Lakatta, EG; Monticone, R; Pauly, RR | 1 |
| Basic, N; Basic, V; Bulic, K; Grgic, M; Kleinman, HK; Luyten, FP; Vukicevic, S | 1 |
| Kim, SK; Lee, JW; Lee, YS; Moon, BJ; Shen, ZJ | 1 |
| Amagasa, T; Ishihara, K; Isobe, M; Mori, M; Nakabayashi, N; Yamazaki, Y | 1 |
| Böhmer, RM | 1 |
| Castellanous, EJ; Ishibashi, H; Kaneda, Y; Nakagawa, K; Nakashima, Y; Onimaru, M; Shirasuna, K; Sueishi, K | 1 |
| Balupuri, S; Booth, TA; Gerstenkorn, C; Kirby, JA; Mohamed, MA; Robertson, H; Talbot, D | 1 |
| Lu, L; Mikos, AG; Yaszemski, MJ | 1 |
| Dehghani, F; Hailer, NP; Hischebeth, GT; Korf, HW; Roser, N; Wirjatijasa, F | 1 |
| Komori, K; Kume, M; Matsumoto, T; Onohara, T; Sugimachi, K; Takeuchi, K; Yonemitsu, Y | 1 |
| Chrisman, CJ; Hogaboam, C; Jakubzick, C; Kolodsick, JE; McKenzie, A; Moore, BB; Moore, TA; Toews, GB; Wilke, CA | 1 |
| Brown, JK; Knight, PA; Miller, HR; Pate, JA; Pemberton, AD; Thornton, EM; Wright, SH | 1 |
| Eickelberg, O; Hecker, M; Krick, S; Seay, U; Sedding, D; Seeger, W | 1 |
| Araújo-Jorge, TC; Bailly, S; Degrave, W; Feige, JJ; Keramidas, M; Meirelles, Mde N; Mendonça-Lima, L; Paciornik, S; Soeiro, Mde N; Waghabi, MC | 1 |
| Bozza, M; De Souza, W; Gonçalves, JG; Martinez, R; Moura-Neto, V; Rozenfeld, C; Sant'anna, C; Seabra, S | 1 |
| Cummins, J; Huard, J; Li, Y; Shen, W; Tang, Y | 1 |
| Castañares, C; Lamas, S; Magán-Marchal, N; Redondo-Horcajo, M; Rodríguez-Pascual, F; ten Dijke, P | 1 |
| An, X; Chen, X; Du, X; Jin, H; Kang, Y; Song, X; Tai, P; Wang, B; Wang, J; Wang, S; Xia, G; Yan, J; Zhao, L | 1 |
| Capito, RM; Spector, M; Xu, X | 1 |
| Alba Soto, CD; Batalla, E; González Cappa, SM; Poncini, CV; Solana, ME | 1 |
| Chou, Y; Chu, CQ; Jiang, Y; Jiang, Z; Zhao, L | 1 |
| Bayry, J; Delignat, S; Dimitrov, JD; Kaveri, SV; Lacroix-Desmazes, S; Pashov, A; Pashova, S; Planchais, C; Rayes, J; Varthaman, A | 1 |
| Karrow, NA; Shandilya, UK; Xu, R; Yiannikouris, A | 1 |
| Furuhashi, M; Hikage, F; Ida, Y; Ohguro, H; Sato, T; Suzuki, S; Tsugeno, Y; Umetsu, A; Watanabe, M | 1 |
25 other study(ies) available for fluorescein-5-isothiocyanate and transforming growth factor beta
| Article | Year |
|---|---|
Establishment and characterization of a clonal line of parathyroid endothelial cells.
Topics: Animals; Capillaries; Cattle; Cell Division; Clone Cells; Culture Techniques; Endothelium, Vascular; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Kinetics; Parathyroid Glands; Phenotype; Platelet-Derived Growth Factor; Thiocyanates; Transforming Growth Factor beta | 1990 |
TGF beta-1 receptor expression and cell cycle analysis of vascular smooth muscle cells from young and aged rats.
Topics: Aging; Animals; Aorta, Thoracic; Cell Cycle; Cells, Cultured; DNA; Flow Cytometry; Fluorescein-5-isothiocyanate; Muscle Development; Muscle, Smooth, Vascular; Ploidies; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta | 1993 |
TGF-beta and basement membrane matrigel stimulate the chondrogenic phenotype in osteoblastic cells derived from fetal rat calvaria.
Topics: Alkaline Phosphatase; Animals; Basement Membrane; Cartilage; Cell Differentiation; Cells, Cultured; Collagen; Drug Combinations; Extracellular Matrix; Fluorescein-5-isothiocyanate; Immunohistochemistry; Laminin; Mesoderm; Osteoblasts; Osteocalcin; Phenotype; Proteoglycans; Radioimmunoassay; Rats; Rats, Inbred F344; Transforming Growth Factor beta | 1996 |
Inhibition of transforming growth factor-beta 2 expression with phosphorothioate antisense oligonucleotides in U937 cells.
Topics: Antineoplastic Agents; Blotting, Western; Cation Exchange Resins; Cell Division; Codon, Initiator; Dose-Response Relationship, Drug; Drug Carriers; Drug Evaluation, Preclinical; Fluorescein-5-isothiocyanate; Humans; Indicators and Reagents; Lipids; Oligonucleotides, Antisense; Oxidation-Reduction; Phosphorus Compounds; RNA, Messenger; Thionucleotides; Transforming Growth Factor beta; U937 Cells | 1999 |
The role of recombinant human bone morphogenetic protein-2 in PLGA capsules at an extraskeletal site of the rat.
Topics: Alkaline Phosphatase; Animals; Bone Development; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Capsules; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Histocytochemistry; Humans; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Prostheses and Implants; Rats; Rats, Wistar; Recombinant Proteins; Transforming Growth Factor beta | 1999 |
Flow cytometry of erythropoiesis in culture: bivariate profiles of fetal and adult hemoglobin.
Topics: Antimetabolites; Benzimidazoles; Bromodeoxyuridine; Cell Separation; Cells, Cultured; Coculture Techniques; DNA; Erythroblasts; Erythropoiesis; Female; Fetal Hemoglobin; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Hemoglobin A; Hemoglobin, Sickle; Humans; In Situ Hybridization, Fluorescence; Leukocytes, Mononuclear; Male; Phycoerythrin; Transforming Growth Factor beta | 2001 |
Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities.
Topics: Adenocarcinoma; Binding Sites; Cell Division; Cell Movement; Endothelial Growth Factors; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Glioblastoma; Humans; Liposomes; Lung Neoplasms; Lymphokines; Neoplasm Invasiveness; Oligonucleotides; Respirovirus; RNA, Messenger; Sp1 Transcription Factor; Thromboplastin; Transcriptional Activation; Transfection; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Active TGF-beta1 expression in kidney transplantation: a comparative study of cyclosporin-A (CyA) and tacrolimus (FK506).
Topics: Biopsy; Cyclosporine; Fluorescein-5-isothiocyanate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Microscopy, Confocal; Tacrolimus; Transforming Growth Factor beta | 2000 |
TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function.
Topics: Animals; Biocompatible Materials; Biodegradation, Environmental; Bone Marrow Cells; Cell Differentiation; Cell Division; Cells, Cultured; Drug Carriers; Fluorescein-5-isothiocyanate; Male; Microscopy, Electron, Scanning; Microspheres; Osteoblasts; Polyethylene Glycols; Polyglactin 910; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Serum Albumin, Bovine; Stromal Cells; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Astrocytic factors protect neuronal integrity and reduce microglial activation in an in vitro model of N-methyl-D-aspartate-induced excitotoxic injury in organotypic hippocampal slice cultures.
Topics: Animals; Astrocytes; Brain Injuries; Cell Communication; Cell Death; Cell Size; Cells, Cultured; Culture Media, Conditioned; Dentate Gyrus; Disease Models, Animal; Down-Regulation; Excitatory Amino Acid Agonists; Fluorescein-5-isothiocyanate; Gliosis; Growth Substances; Hippocampus; Lectins; Microglia; Microscopy, Confocal; N-Methylaspartate; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Rats; Rats, Wistar; Transforming Growth Factor beta | 2001 |
Administration of a decoy against the activator protein-1 binding site suppresses neointimal thickening in rabbit balloon-injured arteries.
Topics: Adult; Animals; Binding Sites; Binding, Competitive; Carotid Artery Injuries; Carotid Artery, Common; Carotid Stenosis; Catheterization; Cell Count; Cell Division; Cells, Cultured; Disease Models, Animal; DNA; Fluorescein-5-isothiocyanate; Genetic Therapy; Humans; Liposomes; Male; Muscle, Smooth, Vascular; Oligonucleotides; Rabbits; Sendai virus; Transcription Factor AP-1; Transfection; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tunica Intima | 2002 |
Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts.
Topics: Animals; Cell Count; Collagen; Cytokines; Down-Regulation; Fibroblasts; Fluorescein-5-isothiocyanate; Genetic Predisposition to Disease; Genotype; Inflammation; Interleukin-13; Interleukin-13 Receptor alpha1 Subunit; Interleukin-4; Mice; Mice, Inbred BALB C; Mice, Knockout; Pulmonary Eosinophilia; Pulmonary Fibrosis; Receptors, Interleukin; Receptors, Interleukin-13; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Expression of integrin-alphaE by mucosal mast cells in the intestinal epithelium and its absence in nematode-infected mice lacking the transforming growth factor-beta1-activating integrin alphavbeta6.
Topics: Animals; Antigens, CD; Antigens, Neoplasm; Blotting, Western; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Gene Deletion; Immunoglobulin G; Immunohistochemistry; Integrin alpha Chains; Integrins; Intestinal Mucosa; Jejunum; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Knockout; Microscopy, Confocal; Nematode Infections; Reverse Transcriptase Polymerase Chain Reaction; RNA; Transforming Growth Factor beta; Transforming Growth Factor beta1; Trichinella spiralis | 2004 |
Transforming growth factor-beta-dependent growth inhibition in primary vascular smooth muscle cells is p38-dependent.
Topics: Animals; Aorta; Apoptosis; Blotting, Western; Cell Division; Cells, Cultured; Endothelium, Vascular; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Genes, Reporter; Indoles; Luciferases; Male; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Time Factors; Transforming Growth Factor beta | 2005 |
Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completion.
Topics: Actins; Animals; Cells, Cultured; Chagas Disease; Embryo, Mammalian; Embryo, Nonmammalian; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Immunohistochemistry; Indoles; Life Cycle Stages; Mice; Microscopy, Confocal; Myocytes, Cardiac; Phalloidine; Recombinant Proteins; Rhodamines; Time Factors; Transforming Growth Factor beta; Trypanosoma cruzi | 2005 |
Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia.
Topics: Animals; Animals, Newborn; Antibodies; Cells, Cultured; Coculture Techniques; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Glycoproteins; Immunohistochemistry; Interferon-gamma; Interleukin-10; Mice; Mice, Inbred BALB C; Microglia; Nerve Degeneration; Neurites; Neurons; Neutralization Tests; Toxoplasma; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis.
Topics: Animals; Antibodies, Monoclonal; Blotting, Western; Cell Culture Techniques; Cell Differentiation; Cell Extracts; Cell Proliferation; Cells, Cultured; Collagen; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Fibrosis; Flow Cytometry; Fluorescein; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Direct; Fluorescent Dyes; Immunohistochemistry; Indoles; Kinetics; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Models, Anatomic; Muscle, Skeletal; Myostatin; Nitrobenzenes; Regeneration; Staining and Labeling; Stem Cells; Sulfonamides; Transforming Growth Factor beta; Transforming Growth Factor beta1; Wound Healing | 2005 |
Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferation.
Topics: Activin Receptors, Type I; Animals; Aorta, Thoracic; Blotting, Western; Cattle; Cell Movement; Cell Proliferation; Cells, Cultured; Endothelial Cells; Endothelin-1; Endothelium, Vascular; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gene Expression Regulation; Genes, Reporter; Kinetics; Luciferases; Microscopy, Fluorescence; Promoter Regions, Genetic; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Transfection; Transforming Growth Factor beta | 2007 |
Induction of regulatory T cells by physiological level estrogen.
Topics: Animals; Animals, Outbred Strains; Biomarkers; CD4 Antigens; Cells, Cultured; Coculture Techniques; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Forkhead Transcription Factors; Fulvestrant; Immune Tolerance; Immunomagnetic Separation; Injections, Subcutaneous; Interleukin-10; Interleukin-2 Receptor alpha Subunit; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred C57BL; Ovariectomy; Pregnancy; Spleen; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Uterus | 2008 |
Plasmid size influences chitosan nanoparticle mediated gene transfer to chondrocytes.
Topics: Biocompatible Materials; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Chitosan; Chondrocytes; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gene Transfer Techniques; Green Fluorescent Proteins; Humans; Light; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanoparticles; Plasmids; Scattering, Radiation; Transforming Growth Factor beta | 2008 |
Trypanosoma cruzi induces regulatory dendritic cells in vitro.
Topics: Animals; Bone Marrow Cells; Cell Differentiation; Cells, Cultured; Dendritic Cells; Dextrans; Fluorescein-5-isothiocyanate; Gene Expression Regulation; Genes, MHC Class II; Interleukin-10; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Transforming Growth Factor beta; Trypanosoma cruzi; Up-Regulation | 2008 |
Analysis of IL-17 production by flow cytometry and ELISPOT assays.
Topics: Animals; Antibodies; Brefeldin A; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Inflammation; Interleukin-17; Interleukin-6; Ionomycin; Mice; Mice, Inbred C57BL; Phycoerythrin; Quinolinium Compounds; Tetradecanoylphorbol Acetate; Th17 Cells; Transforming Growth Factor beta | 2014 |
Stimulation with FITC-labeled antigens confers B cells with regulatory properties.
Topics: Animals; B-Lymphocyte Subsets; B-Lymphocytes; B-Lymphocytes, Regulatory; CD4-Positive T-Lymphocytes; Cell Differentiation; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Female; Fluorescein; Fluorescein-5-isothiocyanate; Interleukin-10; Interleukins; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; T-Lymphocytes, Regulatory; Transforming Growth Factor beta | 2020 |
Ochratoxin A and Citrinin Differentially Modulate Bovine Mammary Epithelial Cell Permeability and Innate Immune Function.
Topics: Animals; Cattle; Citrinin; Claudin-3; Dextrans; Epithelial Cells; Fluorescein-5-isothiocyanate; Immunity; Interleukin-6; Occludin; Ochratoxins; Permeability; Tissue Distribution; Toll-Like Receptor 4; Transforming Growth Factor beta | 2022 |
FGF-2 enhances fibrogenetic changes in TGF-β2 treated human conjunctival fibroblasts.
Topics: Cells, Cultured; Dextrans; Fibroblast Growth Factor 2; Fibroblasts; Fluorescein-5-isothiocyanate; Glucose; Humans; Matrix Metalloproteinases; RNA, Messenger; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta; Transforming Growth Factor beta2; Transforming Growth Factors | 2022 |